pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda recalls·2h ago·1 min read
save

Kofinas Olive Oil voluntarily recalls garlic-infused extra virgin olive oil over unapproved essential oil

Aug 31, 2026·read at fda recalls ↗CRLNeutral

LMSI LLC/Kofinas Olive Oil announced a voluntary recall of its Garlic Mediterranean infused extra virgin olive oil because it contains a garlic essential oil not approved for culinary use.

The product was sold in 500 ml, 250 ml, and 100 ml glass bottles and was available from August 31, 2025 through August 27, 2026 at two Cincinnati stores and online.

No illnesses have been reported; consumers who experience any reaction are advised to seek medical attention and can obtain a full refund by contacting the company.

source

This writeup was produced by pharmadog from original reporting by fda recalls.

Original headline: “LMSI LLC/Kofinas Olive Oil Issues a Voluntary Recall of its Garlic Mediterranean Infused Extra Virgin Olive Oil for Using a Garlic Essential Oil Not Approved for Culinary Use”

read at fda recalls ↗
224 words · retrieved 54m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Recall6

related stories

  • Jul 21Biotech industry leaders file brief backing FDA against ‘malicious’ mifepristone challengeFierce Biotech
  • Jul 21STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and moreSTAT
  • Jul 21A renewed push from the right against abortion pillsSTAT
  • Jul 20FDA still focused on lettuce supplier as source of parasite, despite faulty test resultSTAT
  • Jul 17STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and moreSTAT